Lv2
120 积分 2025-06-05 加入
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
13天前
已完结
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
18天前
已完结
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
19天前
已关闭
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
19天前
已完结
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
1个月前
已关闭
Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults
1个月前
已完结
Metabolic Adaptations to Weight Loss: A Brief Review
1个月前
已完结
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial
1个月前
已完结
Weight loss: Lifestyle interventions and pharmacotherapy
1个月前
已完结
Skeletal muscle loss and sarcopenia in obesity pharmacotherapy
1个月前
已完结
皖公网安备34019202002308
